The manufacturing process should remain the focus for severe febrile reactions in children administered an Australian inactivated influenza vaccine during 2010

Influenza vaccine safety is an ongoing issue. In 2010, inactivated trivalent influenza vaccines (TIVs), Fluvax(®) and Fluvax Junior(®) manufactured by CSL Biotherapies (‘CSL’), Parkville, Australia, were associated with a marked increase in febrile seizures (FS) in children <5 years old. Extensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Li‐Kim‐Moy, Jean, Booy, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687502/
https://www.ncbi.nlm.nih.gov/pubmed/26258888
http://dx.doi.org/10.1111/irv.12337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687502/
https://www.ncbi.nlm.nih.gov/pubmed/26258888
http://dx.doi.org/10.1111/irv.12337

Ejemplares similares